These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 8898356)

  • 21. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein.
    Ambudkar SV; Cardarelli CO; Pashinsky I; Stein WD
    J Biol Chem; 1997 Aug; 272(34):21160-6. PubMed ID: 9261121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time monitoring of P-glycoprotein activation in living cells.
    Landwojtowicz E; Nervi P; Seelig A
    Biochemistry; 2002 Jun; 41(25):8050-7. PubMed ID: 12069596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein.
    Wang E; Casciano CN; Clement RP; Johnson WW
    Cancer Res; 2001 Oct; 61(20):7525-9. PubMed ID: 11606389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analysis of a tryptophan-less P-glycoprotein: a tool for tryptophan insertion and fluorescence spectroscopy.
    Kwan T; Loughrey H; Brault M; Gruenheid S; Urbatsch IL; Senior AE; Gros P
    Mol Pharmacol; 2000 Jul; 58(1):37-47. PubMed ID: 10860925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P-glycoprotein substrates and antagonists cluster into two distinct groups.
    Scala S; Akhmed N; Rao US; Paull K; Lan LB; Dickstein B; Lee JS; Elgemeie GH; Stein WD; Bates SE
    Mol Pharmacol; 1997 Jun; 51(6):1024-33. PubMed ID: 9187269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells.
    Bello-Reuss E; Ernest S; Holland OB; Hellmich MR
    Am J Physiol Cell Physiol; 2000 Jun; 278(6):C1256-65. PubMed ID: 10837354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.
    Sharom FJ; Yu X; Lu P; Liu R; Chu JW; Szabó K; Müller M; Hose CD; Monks A; Váradi A; Seprôdi J; Sarkadi B
    Biochem Pharmacol; 1999 Aug; 58(4):571-86. PubMed ID: 10413294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein.
    Müller M; Bakos E; Welker E; Váradi A; Germann UA; Gottesman MM; Morse BS; Roninson IB; Sarkadi B
    J Biol Chem; 1996 Jan; 271(4):1877-83. PubMed ID: 8567633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.
    Loo TW; Clarke DM
    Biochemistry; 1994 Nov; 33(47):14049-57. PubMed ID: 7947814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the human P-glycoprotein ATPase by trypsin.
    Nuti SL; Mehdi A; Rao US
    Biochemistry; 2000 Mar; 39(12):3424-32. PubMed ID: 10727237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system.
    Kimchi-Sarfaty C; Gribar JJ; Gottesman MM
    Mol Pharmacol; 2002 Jul; 62(1):1-6. PubMed ID: 12065748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
    Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
    Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
    Cole SP; Sparks KE; Fraser K; Loe DW; Grant CE; Wilson GM; Deeley RG
    Cancer Res; 1994 Nov; 54(22):5902-10. PubMed ID: 7954421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional expression of human P-glycoprotein from plasmids using vaccinia virus-bacteriophage T7 RNA polymerase system.
    Hrycyna CA; Ramachandra M; Pastan I; Gottesman MM
    Methods Enzymol; 1998; 292():456-73. PubMed ID: 9711574
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein.
    Safa AR; Stern RK; Choi K; Agresti M; Tamai I; Mehta ND; Roninson IB
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7225-9. PubMed ID: 1976255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
    De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
    J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes.
    Park S; Majd S
    PLoS One; 2018; 13(6):e0199279. PubMed ID: 29912971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol.
    Luker GD; Nilsson KR; Covey DF; Piwnica-Worms D
    J Biol Chem; 1999 Mar; 274(11):6979-91. PubMed ID: 10066752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.
    Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM
    Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.